Systemic Lupus Eyrthematosus: Investigating a Transforming Therapeutic Landscape
- /
- /
Check out this engaging SLE Learning Pathway where you can find: A downloadable Frequently Asked Questions resource providing concise information on common…
Blog
Articles with Educational information and Resources
Trusted, human-reviewed articles across rheumatological, autoimmune and neurological conditions, for patients and the care-partners.
September 3, 2026
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
- /
- /
ClinicalTrials.gov ID NCT07355218Sponsor EMD Serono Research & Development Institute, Inc.Information provided by EMD Serono (EMD Serono Research & Development Institute,…
August 13, 2026
J&J’s Nipocalimab Shows Sustained Reduction in Lupus Disease Activity
- /
- /
- /
June 3rd 2026 Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a…
August 6, 2026
Biomarker Trends Predict Lupus Flares for Challenging Subgroup
- /
- /
— “Serologically active, clinically quiescent” patients don’t always stay that way by John Gever, Contributing Writer, MedPage Today July 31, 2026…
June 25, 2026
Global Survey Finds 58% Know Very Little or Nothing About Lupus
- /
- /
- /
May 5, 2026 Low familiarity and ongoing misconceptions underscore the need for increased education and broader visibility, building on more…
April 30, 2026
Drug Lifts ‘Brain Fog’ From Lupus Patients: Clinical Trial
- /
- /
Vanderbilt Health News, Apr 20, 2026 An estimated 200,000 people in the United States have lupus. About 80% of them…
Stay in the loop
Get new articles as they publish
Join our community and we will send trusted education and updates for your condition.